Adaptive Biotechnologies Competitors and Similar CompaniesClear all
Adaptive Biotechnologies's competitors and similar companies include Personalis, Kalaris Therapeutics, Proteus Digital Health, Juno Therapeutics, Takeda, Navidea Biopharmaceuticals and Kite Pharma.
 Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. |  Kalaris Therapeutics Kalaris Therapeutics (formerly known as AlloVir and ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases. |  Proteus Digital Health Proteus Digital Health is a company developing digital products that collect and aggregate various behavioral, physiological and therapeutic metrics. |  Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Navidea Biopharmaceuticals Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. | |||
Founding Date | Founding Date 2009 | Founding Date 2011 | Founding Date 2013 | Founding Date 2001 | Founding Date 2013 | Founding Date 1781 | Founding Date 1983 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | ||||||||
Locations | Locations Seattle, US HQ New York, US South San Francisco, US | Locations Fremont, US HQ West Wickham, GB | Locations Waltham, US HQ Dublin, IE Milan, IT | Locations Redwood City, US HQ Hayward, US | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US | Locations Dublin, US HQ Thame, GB | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | |
Employees | Employees 70910% decrease | Employees 22344% decrease | Employees 695% decrease | Employees 632% increase | Employees 1091% decrease | Employees 47,4554% decrease | Employees 137% decrease | Employees 3,9671% decrease |
Valuation ($) | Valuation ($) 694.6 m | Valuation ($) 340.9 m | Valuation ($) 103.1 m | Valuation ($) 1.6 b | Valuation ($) N/A | Valuation ($) 43.7 b | Valuation ($) 100.1 k | Valuation ($) N/A |
Financial | ||||||||
Revenue (est.) | Revenue (est.) $277m (FY, 2025) | Revenue (est.) $69.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $111.9m (FY, 2017) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $65.7k (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods $71.4m (FY, 2025) | Cost of goods $53.9m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $1.9k (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit $205.6m (FY, 2025) | Gross profit $15.8m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit ($119.3k) (FY, 2022) | Gross profit N/A |
Net income | Net income ($59.5m) (FY, 2025) | Net income ($81.3m) (FY, 2025) | Net income ($43.4m) (FY, 2025) | Net income N/A | Net income ($437.1m) (FY, 2017) | Net income ¥108.1b (FY, 2025) | Net income ($15.2m) (FY, 2022) | Net income N/A |
Operating ⚠ | ||||||||
Patents (Foreign) | Patents (Foreign) N/A | Patents (Foreign) N/A | Patents (Foreign) 30 (Jul, 2020) | Patents (Foreign) N/A | Patents (Foreign) 86 (FY, 2016) | Patents (Foreign) N/A | Patents (Foreign) N/A | Patents (Foreign) N/A |
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) 2 (Jul, 2020) | Patents (US) N/A | Patents (US) 72 (FY, 2016) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A |
Patents Issued | Patents Issued N/A | Patents Issued 16 (FY, 2021) | Patents Issued N/A | Patents Issued 600 (May, 2020) | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A |
Funding | ||||||||
Total funding raised | Total funding raised $ 525m | Total funding raised $ 75m | Total funding raised $ 159m | Total funding raised $ 517m | Total funding raised $ 310m | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised $ 85.3m |
For sources of this data, please see the company profile
View Company Profiles
Personalis
HQ
Fremont, US
Employees
223↓ 44% decrease
Personalis is a biotechnology company that specializes in cancer genomics.
View companyKalaris Therapeutics
HQ
Waltham, US
Employees
6
Kalaris Therapeutics (formerly known as AlloVir and ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases.
View companyProteus Digital Health
HQ
Redwood City, US
Employees
63↑ 2% increase
Proteus Digital Health is a company developing digital products that collect and aggregate various behavioral, physiological and therapeutic metrics.
View companyJuno Therapeutics
HQ
Seattle, US
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company